Upgrade to SI Premium - Free Trial

Collegium Pharma (COLL) Reports Q4 Loss of $1.02/Share

March 9, 2017 4:20 PM

Collegium Pharma (NASDAQ: COLL) reported Q4 EPS of ($1.02), versus ($0.46) reported last year.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

Categories

Earnings

Next Articles